Key Metrics
H-Index 

38
Scite Index 

0.91 5-Year SI

SJR 

Q1Dermatology

Recommended pre-submission checks
Powered by 

Topics Covered on DERMATOLOGY AND THERAPY
DERMATOLOGY AND THERAPY Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 0 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in DERMATOLOGY AND THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in DERMATOLOGY AND THERAPY
Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study.
- 25 Apr 2026
- Dermatology and therapy
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
- 25 Apr 2026
- Dermatology and therapy
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
- 24 Apr 2026
- Dermatology and therapy
Treatment Patterns and Economic Burden in ModeratetoSevere Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis.
- 24 Apr 2026
- Dermatology and therapy
Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial.
- 22 Apr 2026
- Dermatology and therapy
Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.
- 21 Apr 2026
- Dermatology and therapy
Epigenetic Skin Aging and Its Reversal to Improve Skin Longevity across Ethnicities and Phototypes Using a Dihydromyricetin-Containing Serum: Results from a Prospective, Single-Cohort Study.
- 25 Apr 2026
- Dermatology and therapy
Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
- 25 Apr 2026
- Dermatology and therapy
Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study.
- 24 Apr 2026
- Dermatology and therapy
Treatment Patterns and Economic Burden in ModeratetoSevere Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis.
- 24 Apr 2026
- Dermatology and therapy
Efficacy, Safety, and Tolerability of a Wearable Electrotrichogenic Device in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Sham-Controlled Trial.
- 22 Apr 2026
- Dermatology and therapy
Beyond the Skin: Assessing Itch in Atopic Dermatitis - Insights from UK Dermatologists. A Cross-Sectional Survey and Narrative Review.
- 21 Apr 2026
- Dermatology and therapy